Copertina

Corrigendum: Nuclear‐Targeted Boron‐Lapatinib Hybrid for Enhanced Boron Neutron Capture Therapy in Advanced Thyroid Carcinoma

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Marcos Couto, Martina Buschittari, Marina Carpano, Susana Nievas, Belén Dávila, Antonella Pastini, Ignacio González, Marina Perona, María Sol Espain, Agustina Mariana Portu, Hugo Cerecetto, María Alejandra Dagrosa
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	ChemMedChem
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Nuclear‐Targeted Boron‐Lapatinib Hybrid for Enhanced Boron Neutron Capture Therapy in Advanced Thyroid Carcinoma
di: Marcos Couto, et al.
Pubblicazione: (2026)

Boron in My Mind: A Comprehensive Review of the Evolution of the Diverse Syntheses of 4‐Borono‐ l ‐Phenylalanine, the Leading Agent for Boron Neutron Capture Therapy
di: Sarfraz Ahmad, et al.
Pubblicazione: (2025)

2‐Carboxyquinoline Boronic Acids as Highly Potent KPC Inhibitors
di: Zheng Ma, et al.
Pubblicazione: (2025)

Design, Synthesis, and Evaluation of Boron Dipyrromethene‐Based Fluorescent Probes Targeting BRAF for Melanoma Diagnosis
di: Mengqian Wang, et al.
Pubblicazione: (2025)

Boron Clusters Versus Adamantane: A Comparative Study of Inorganic and Organic Scaffolds Against Resistant Influenza A
di: Timur M. Garaev, et al.
Pubblicazione: (2026)

Identification of Potential Inhibitors of the SARS‐CoV‐2 NSP13 Helicase via Structure‐Based Ligand Design, Molecular Docking and Nonequilibrium Alchemical Simulations
di: Giorgio Di Paco, et al.
Pubblicazione: (2024)

Front Cover: Identification of Potential Inhibitors of the SARS‐CoV‐2 NSP13 Helicase via Structure‐Based Ligand Design, Molecular Docking and Nonequilibrium Alchemical Simulations (ChemMedChem 10/2024)
di: Giorgio Di Paco, et al.
Pubblicazione: (2024)

Synthesis of Novel Fluorinated Febrifugine Analogs and Evaluation of Their Antifungal Activity
di: Fahad Alkhathami, et al.
Pubblicazione: (2026)

Spiro‐Acridine Compound as a Pteridine Reductase 1 Inhibitor: in silico Target Fishing and in vitro Studies
di: Jéssika de Oliveira Viana, et al.
Pubblicazione: (2024)

Benzoxazole‐Acrylonitriles: Dual Bioactivity and DNA Binding from a Sustainable Synthetic Approach
di: Marina Galić, et al.
Pubblicazione: (2025)

N,N‐Diarylsulfonamide Reduces Proinflammatory Cytokine Interleukin‐6 Levels in Cells through Nuclear Factor‐κB Regulation
di: Dattatraya A. Babar, et al.
Pubblicazione: (2024)

Investigating the Ligand‐Binding Properties of N‐arylbenzimidazoles as Novel Elastase Inhibitors
di: Giovanna Pitasi, et al.
Pubblicazione: (2025)

Toward Anti‐Herpesviral PROTACs: Assessing the Challenges for Targeted Protein Degradation on the Example of Kaposi's Sarcoma‐Associated Herpesvirus Latency‐Associated Nuclear Antigen
di: Aylin Berwanger, et al.
Pubblicazione: (2025)

Developing Allosteric Inhibitors of SARS‐CoV‐2 RNA‐Dependent RNA Polymerase
di: Artem Chayka, et al.
Pubblicazione: (2024)

Allosteric Inhibitors of SARS‐CoV‐2 RNA‐Dependent RNA Polymerase Based on N , N′ ‐Diphenylurea
di: Artem Chayka, et al.
Pubblicazione: (2025)

C1′‐Branched Acyclic Nucleoside Phosphonates as Inhibitors of Plasmodium Falciparum 6‐Oxopurine Phosphoribosyltransferase
di: Jan Frydrych, et al.
Pubblicazione: (2025)

Exploring the Utility of Cell‐Penetrating Peptides as Vehicles for the Delivery of Distinct Antimalarial Drug Cargoes
di: Caitlin L. Gare, et al.
Pubblicazione: (2024)

Ergosterol and Lanosterol Derivatives: Synthesis and Possible Biomedical Applications
di: Joanna Stefaniak‐Skorupa, et al.
Pubblicazione: (2025)

The Therapeutic Potential in Cancer of Terpyridine‐Based Metal Complexes Featuring Group 11 Elements
di: María Gil‐Moles, et al.
Pubblicazione: (2024)

The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit to Lead
di: Jean Quancard, et al.
Pubblicazione: (2025)

Cover Feature: The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit to Lead (ChemMedChem 8/2025)
di: Jean Quancard, et al.
Pubblicazione: (2025)

Exploring the Anticancer Properties and Mode of Action of Copper(II)‐Furan Acylhydrazone on Human Triple Negative Breast Cancer Cells
di: Lucía Santa Maria de la Parra, et al.
Pubblicazione: (2026)

Biaryl Phosphate‐Based Inhibitors of the Transcription Factor STAT4
di: Nadiya Brovchenko, et al.
Pubblicazione: (2025)

Synthesis and Medicinal Applications of N‐Heterocyclic Carbene Complexes Based on Caffeine and Other Xanthines
di: Giulia Francescato, et al.
Pubblicazione: (2024)

Evaluation of a Radioiodinated G‐Quadruplex Binder in Cervical Cancer Models
di: ]Maria Cristina Oliveira, et al.
Pubblicazione: (2024)

The French Medicinal Chemistry Society–SCT, an Historical Member of EFMC**
di: Rebecca Deprez‐Poulain, et al.
Pubblicazione: (2024)

Optimization of 4‐Amino‐2‐Pyridone Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9: Integrating Structure–Activity and Structure–Metabolism Relationships
di: Lisa Giannessi, et al.
Pubblicazione: (2025)

Synthesis, Biological Evaluation, and Theoretical Study of Indenoquinolinylphosphine Oxide Derivatives as Topoisomerase 1 Inhibitors and Antiproliferative Agents
di: Alba Rodriguez, et al.
Pubblicazione: (2026)

Replacing a Cereblon Ligand by a DDB1 and CUL4 Associated Factor 11 (DCAF11) Recruiter Converts a Selective Histone Deacetylase 6 PROTAC into a Pan‐Degrader
di: Felix Feller, et al.
Pubblicazione: (2025)

Flavonoid Oxime Carbamate Derivatives: Reversal of Multidrug Resistance in Cancer Cells
di: Filipa Barbosa, et al.
Pubblicazione: (2026)

Addressing Data Point Homogeneity and Annotation Challenges to Enhance Data‐Driven Approaches: The S. aureus NorA Efflux Pump Case Study
di: Andrea Astolfi, et al.
Pubblicazione: (2025)

Positively Charged Polymers Based on Cyclodextrins for Trametinib and Selumetinib Delivery in Glioblastoma Cancer
di: Noemi Bognanni, et al.
Pubblicazione: (2026)

Profiling Cysteine Proteases Activities in Neuroinflammatory Cells
di: Laura Agost‐Beltrán, et al.
Pubblicazione: (2024)

Combinatorial Libraries of Bipodal Binders of the Insulin Receptor
di: Irena Selicharová, et al.
Pubblicazione: (2024)

Tetrahydroindolone‐Dihydropyrimidinone Hybrids as Promising Antibiofilm and Antibacterial Agents
di: Vinicius Vendrusculo, et al.
Pubblicazione: (2025)

GDF15 Analogues Acting as GFRAL Ligands
di: Andrea Di Santo, et al.
Pubblicazione: (2025)

Targeting Ubiquitin‐Specific Protease 7 with Novel 5‐Amino‐Pyrazole Inhibitors: Design, Synthesis, and Biological Evaluation
di: Matteo Lusardi, et al.
Pubblicazione: (2025)

Cytotoxic, Antibacterial, and in Silico Pks13 Inhibitory Properties of Indole‐Coupled Dihydrobenzo[c]phenanthridines
di: Reyna Martha Gallegos‐Alvarado, et al.
Pubblicazione: (2025)

Front Cover: Functional Proteomics of Quinazolin‐4‐One Derivatives Targeting the Proteasome (ChemMedChem 2/2026)
di: Elva Morretta, et al.
Pubblicazione: (2026)

Novel DAG‐Lactone‐Based Vav1 Inhibitors Show Anti‐proliferative Activity in Pancreatic Cancer Models
di: Ana Bellomo, et al.
Pubblicazione: (2025)